Nasir cv website
Yüklə 230,22 Kb. Pdf görüntüsü
|
08/04/2010
6. Double Blind, Placebo-‐Controlled, Multicenter Study Evaluating the Efficacy and Safety of Different Oral Dose Levels of Dofetilide in the Prevention of Recurrence of Atrial Fibrillation/Flutter in Patients with Chronic Persistent Atrial Fibrillation/Flutter Converted Electrically or Pharmacologically to Sinus Rhythm a. 1993-‐1995 b. The Methodist Hospital c. Co-‐Investigator 7. Model 7219D PCD Pace-‐Cardioverter-‐Defibrillator with Transvene and Epicardial Lead Systems a. 1993-‐1994 b. The Methodist Hospital c. Co-‐Investigator 8. Open Label Safety Study of I.V. Amiodarone HCL in Patients with Life-‐Threatening Ventricular Tachycardia/Fibrillation a. 1993-‐1995 b. The Methodist Hospital c. Co-‐Investigator 9. D-‐Sotatlol for the Treatment of Life-‐Threatening Refractory Ventricular Arrhythmias a. 1993-‐1995 b. The Methodist Hospital c. Co-‐Investigator 10. Dose-‐Ranging Study of Oral Bidisomide vs. Placebo in Reducing the Recurrence of Symptomatic Atrial Fibrillation/Flutter and Paroxysmal Supraventricular Tachycardia a. 1993-‐1995 b. The Methodist Hospital c. Co-‐Investigator 11. I.V. d-‐Sotalol Ventricular Tachycardia Termination Study a. 1993-‐1995 b. The Methodist Hospital c. Co-‐Investigator 12. An Open Label, Long-‐Term Extension Study of Orally Administered Dofetilide in Patients with an Implanted Arrhythmia Control Device a. 1993-‐2000 b. The Methodist Hospital c. Co-‐Investigator 13. Cadence TVL (Transvenous Lead) System a. 1993-‐1994 b. The Methodist Hospital c. Co-‐Investigator 14. Model 7202 PCD Defibrillator with Transvene and Epicardial Lead Systems a. 1994-‐1995 b. The Methodist Hospital c. Co-‐Investigator 15. Cadence V110 a. 1994-‐1995 b. The Methodist Hospital] c. Co-‐Investigator 16. Jewel PCD 7219C Active Can System Model 7219C a. 1994-‐1995 b. The Methodist Hospital c. Co-‐Investigator 17. A Ramdomized, Double-‐Blind, Parallel. Placebo-‐Controlled Evaluation of Orally Administered Dofetilide in Patients with Symptomatic Paroxysmal Atrial Fibrillation/Flutter (pAP, pAFL Or Paroxysmal Supraventricular Tachycardia (pSVT)
08/04/2010
a. 1994-‐1996 b. The Methodist Hospital c. Co-‐Investigator 18. A Double-‐Blind, Placebo-‐Controlled Trial of the Efficacy and Safety of Two Doses of Oral Cordarone (Amiodarone HCL) in the Treatment of Patients with Refractory, Symptomatic, Paroxysmal Atrial Fibrillation/Flutter a. 1994-‐1997 b. The Methodist Hospital c. Co-‐Investigator 19. Efficacy and Safety of d-‐Sotalol Versus Placebo in the Maintenance of Sinus Rhythm Following Pharmacologic or Electrical Cardioversion in Subjects in Sustained Atrial Fibrillation or Atrial Flutter a. 1995 b. The Methodist Hospital c. Co-‐Investigator 20. Cadence V112 a. 1995 b. The Methodist Hospital c. Co-‐Investigator 21. Candence TVL System Cadet V115 and V105 Pulse Generator Pectoral Placement a. 1995 b. The Methodist Hospital c. Co-‐Investigator 22. Pectoral Evaluation of 1720 and 1725 Ventak PRxIII Endotak Lead System a. 1995-‐1996 b. The Methodist Hospital c. Co-‐Investigator 23. Double-‐Blind, Placebo-‐Controlled, Multicenter Study Evaluating the Efficacy and Safety of Different Oral Dose Levels of Dofetilide in the Prevention of Recurrence of Atrial Fibrillation/Flutter in Patients with Chronic Persistent Atrial Fibrillation/Flutter Converted Electrically or Pharmacologically to Sinus Rhythm a. 1995-‐1996 b. The Methodist Hospital c. Co-‐Investigator 24. Placebo-‐Controlled Evaluation of the Efficacy and Safety or Oral Sotalol in Patients with Life-‐Threatening Ventricular Arrhythmias and Implanted Cardioverter Defibrillators a. 1995-‐1997 b. The Methodist and St. Luke’s Episcopal Hospitals c. Co-‐Investigator 25. Cadence TVL Systems Cadet High Voltage Can Converter Defibrillator Model V105AC-‐115AC a. 1996 b. The Methodist Hospital c. Co-‐Investigator 26. Randomized, Double-‐Blind, Parallel, Placebo-‐Controlled Evaluation or Orally Administered Dofetilide in Subjects with Symptomatic Paroxysmal Atrial Fibrillation/Flutter (pAF, pAFL) a. 1996 b. Texas Arrhythmia Institute c. Co-‐Investigator 27. TVL Defibrillation Lead System Clinical Investigation: Addition of Contour High Voltage Can Cardioverter/Defibrillator (Model V-‐135AC/V-‐145AC) a. 1996 b. The Methodist Hospital c. Co-‐Investigator
08/04/2010
28. Clinical Evaluation of the Res-‐Q II Defibrillation System a. 1996 b. The Methodist Hospital c. Co-‐Investigator 29. Model 7219PW Biphasic Tilt-‐Study: Custom Pulse Width Software a. 1996-‐1998 b. Texas Arrhythmia Institute c. Co-‐Investigator 30. Model 7221CX System Reduced Output Study (Micro Jewel), a. 1996-‐1998 b. Texas Arrhythmia Institute c. Co-‐Investigator 31. Constellation Multiple Electrode Mapping Catheter System: Study for Mapping and Pacing of a Heart Chamber During Electrophysiologic Evaluation a. 1996-‐1998 b. The Methodist Hospital c. Co-‐Investigator 32. Arginine Infusion During Upright Tilt Test a. 1996-‐1998 b. The Methodist Hospital c. Co-‐Investigator 33. Clinical Investigation for Res-‐Q Micron ACD System with Intervene Lead System a. 1996-‐1998 b. The Methodist Hospital c. Co-‐Investigator 34. Sentinel 2000 Implantable Defibrillation System U.S. Clinical Study a. 1996-‐1999 b. Texas Arrhythmia Institute c. Co-‐Investigator 35. Effect of Proximal vs. Distal Electrode Position on Ventricular DFT Using the Model 2394 External Cardioverter Defibrillator a. 1997 b. The Methodist Hospital c. Co-‐Investigator 36. Randomized, Double-‐Blind, Placebo-‐Controlled Trial of Weekly Azithromycin on the Incidence of Coronary Artery Disease in Subjects with Evidence of Exposure to C Pneumoniae a. 1997 b. The Methodist Hospital c. Co-‐Investigator 37. Ventak AVII DR Acute Tachy Study a. 1997-‐1998 b. The Methodist Hospital c. Co-‐Investigator 38. Evaluation of Efficacy of Thermister Catheter with Radiofrequency Generator for Atrial Arrhythmias a. 1997-‐1998 b. The Methodist Hospital c. Co-‐ Investigator 39. Ventritex Contour MD/Angstrom MD Clinical Investigation a. 1997-‐1998 b. The Methodist Hospital c. Co-‐Investigator Yüklə 230,22 Kb. Dostları ilə paylaş:
|